ACAD Stock Slumps to 5-Month Low on Schizophrenia Setback
ACAD stock is taking a major hit today, slumping to a new 5-month low after Acadia Pharmaceuticals Inc (NASDAQ:ACAD)’s schizophrenia treatment did not pass a late-stage clinical trial. Disappointing News Clinical trials are extremely important ... [Read]
AMRN Stock Rockets 13% As Amarin Sees Strong Revenues
AMRN has been on a tear on Tuesday and has gone up by as much as 13% as Amarin Corporation plc (NASDAQ:AMRN) raised its projections for the company’s revenues for the year 2019. Revenue Projection ... [Read]
ARRY Stock Hits All-Time High on Pfizer’s Acquisition
ARRY stock is witnessing a solid day after Pfizer Inc (NYSE:PFE) announced it was acquiring Array Biopharma Inc (NASDAQ:ARRY). 62% Premium on ARRY Stock In a significant development, pharmaceutical giant Pfizer has decided to acquire ... [Read]
ImmunoPrecise to Present at the 2019 Bloom Burton and Co. Healthcare Investor Conference
VICTORIA, April 16, 2019 /CNW/ – ImmunoPrecise Antibodies Ltd. (TSX:IPA)(OTC:IPATF)(FRA: TQB2) (the “Company” or “IPA”)announced today that Jennifer Bath, President and CEO of ImmunoPrecise Antibodies, will present at the upcoming 2019 Bloom Burton & Co. Healthcare Investor Conference. Date: May 1st, ... [Read]
ImmunoPrecise Appoints Andy Nixon to Board of Directors
VICTORIA, April 11, 2019 / – ImmunoPrecise (TSX:IPA)(OTC:IPATF)(FRA: TQB2) (the “Company” or “IPA”) announces that it has appointed Andy Nixon, Vice President of Biotherapeutics Molecule Discovery at Boehringer Ingelheim, as a member of its board of ... [Read]
Advaxis Shares Pop Up 72% On Solid Data For ADXS-NEO
Shares of Advaxis (NASDAQ:ADXS) are up a whopping 72%, selling for $10.20 this morning after the company released improved data for its personalized cancer vaccine candidate ADXS-NEO. The stock is up about 32% year to date ... [Read]
Biogen Alzheimer’s Drug Trial Sees Positive Results, Shares Soar 20%
Biogen Alzheimer’s Drug Trial: Finding a cure for Alzheimer’s disease can look like an impossible mission, even for the most brilliant minds. What isn’t impossible, however, is offering disease-modifying therapies to those suffering from the ... [Read]
Auris Health – Monarch Platform Will Revolutionize Medical Intervention
Silicon Valley-based Auris Health Inc., formerly Auris Surgical Robotics Inc., announced that the company’s Monarch Platform has received clearance from the US Food and Drug Administration. The platform received clearance for diagnostic and therapeutic bronchoscopic ... [Read]
Spark Therapeutics Shares Plunged More Than 40% Today, Here’s Why
On Monday, in early trade, Spark Therapeutics, Inc. (NASDAQ:ONCE) saw its shares plunge more than 40%. What happened? Well, the decline started after the gene therapy biotech company disclosed data from various trials that are ... [Read]
MannKind Corp’s 126% Share Increase in October: Too Good to be True?
The maker of inhaled insulin product Afrezza, MannKind Corp. (NASDAQ:$MNKD) saw its shares rise by another 40% as of afternoon trading. In total, MannKind has seen a whopping 126% share price increase since the beginning ... [Read]